GleamWall
中文EN

ICLR ICON PLC

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1060955

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.4%
TTM net income YoY5.0%
TTM EPS YoY25.8%
Revenue 3-yr CAGR1.4%
Net income 3-yr CAGR-2.8%

Margins

Gross margin23.5%
Operating margin5.3%
Net margin5.4%
FCF margin10.3%
EBITDA margin9.7%

Returns

ROE5.0%
ROA2.8%
ROIC (approx.)3.0%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets43.8%
Debt / equity0.37x
Current ratio1.32x
Interest coverage2.06x

Cash quality & payout

Operating cash flow / net income2.29x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue2.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.02B$2.06B$2.03B$2.19B$2.08B$2.04B$2.02B$2.06B
Cost of revenue$1.53B$1.58B$1.56B$1.69B$1.54B$1.46B$1.45B$1.43B
Gross profit$491.83M$479.29M$477.93M$500.89M$545.46M$583.33M$566.06M$632.74M
SG&A expense$196.85M$194.32M$200.60M$179.70M$197.05M$205.01M$198.38M$151.44M
Operating income$198.84M$137.83M$173.73M-$72.51M-$222.91M$230.94M$226.97M$330.40M
Interest expense$66.17M$48.79M$48.00M$49.49M$50.24M$50.15M$47.61M$51.43M
Pretax income—$92.20M—$159.85M-$271.39M$182.84M$181.16M$347.41M
Income tax$32.45M$19.61M$22.81M-$10.36M$12.79M-$20.67M$20.35M-$12.77M
Net income$122.13M$72.58M$104.75M$149.19M-$284.18M$203.52M$160.81M$347.09M
EBITDA$293.26M$228.60M$264.06M$17.78M-$123.88M$328.66M$322.93M$427.05M
EPS (basic)1.590.941.37—-3.672.572.00—
EPS (diluted)1.580.941.36—-3.672.561.99—
Weighted avg. shares (diluted)77.40M77.37M77.26M—77.37M79.55M80.92M—
Balance sheet
Cash & equivalents$808.98M$928.38M$765.16M$647.29M$468.89M$390.40M$526.70M$538.78M
Short-term investments———$0———$0
Receivables$1.51B$1.46B$1.47B$1.47B$1.39B$1.37B$1.39B$1.39B
Current assets$3.64B$3.75B$3.61B$3.50B$3.34B$3.24B$3.32B$3.28B
PP&E, net$375.26M$385.43M$384.75M$395.72M$377.94M$377.98M$378.25M$382.88M
Goodwill$8.72B$8.72B$8.73B$8.73B$8.73B$9.09B$9.07B$9.05B
Intangibles$3.10B$3.15B$3.20B$3.25B$3.30B$3.44B$3.50B$3.56B
Total assets$16.24B$16.40B$16.32B$16.27B$16.16B$16.54B$16.64B$16.63B
Current liabilities$2.77B$3.93B$3.17B$3.20B$3.23B$2.55B$2.68B$2.64B
Long-term debt$3.38B$2.11B$2.87B$2.87B$2.88B$3.38B$3.39B$3.40B
Total debt$3.38B$2.11B$2.87B$2.87B$2.88B$3.38B$3.39B$3.40B
Total liabilities$7.12B$7.02B$7.02B$7.08B$7.16B$7.04B$7.22B$7.19B
Shareholders' equity$9.13B$9.38B$9.30B$9.19B$8.99B$9.50B$9.43B$9.44B
Net debt$2.57B$1.18B$2.10B$2.23B$2.41B$2.99B$2.86B$2.86B
Shares outstanding74.92M77.15M76.60M76.57M76.36M77.77M79.46M80.76M
Cash flow statement
Operating cash flow$345.14M$281.27M$167.01M$234.16M$387.60M$146.20M$268.24M$338.31M
Capital expenditure$37.99M$42.42M$30.77M$59.33M$53.70M$32.28M$28.91M$61.29M
Free cash flow$307.15M$238.85M$136.24M$174.83M$333.90M$113.92M$239.33M$277.03M
Investing cash flow-$50.58M-$108.34M-$39.44M-$55.94M-$56.10M-$38.21M-$37.28M-$68.88M
Financing cash flow-$413.76M-$8.12M-$6.36M-$5.79M-$256.77M-$255.86M-$252.83M-$403.96M
Depreciation & amortization$94.42M$90.77M$90.33M$90.29M$99.03M$97.72M$95.96M$96.66M
Stock-based compensation$18.01M$19.44M$27.57M$29.51M$46.19M$15.43M$12.36M$4.69M
Share buybacks$400.00M$0$0$0$250.00M$250.00M$250.00M$400.00M

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.